TC-2216

From Wikipedia, the free encyclopedia
Jump to: navigation, search
TC-2216
TC-2216 structure.png
Identifiers
PubChem (CID) 10176607
ChemSpider 8352112
Chemical and physical data
Formula C12H17N3
Molar mass 203.283
3D model (Jmol) Interactive image
  (verify)

TC-2216 is a drug developed by Targacept which acts as a partial agonist at neural nicotinic acetylcholine receptors and is being researched for the treatment of anxiety and depression.[1]

References[edit]

  1. ^ Romanelli, M.; Gratteri, P.; Guandalini, L.; Martini, E.; Bonaccini, C.; Gualtieri, F. (2007). "Central nicotinic receptors: structure, function, ligands, and therapeutic potential". ChemMedChem. 2 (6): 746–767. doi:10.1002/cmdc.200600207. PMID 17295372.